$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

$lfcr Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-K Financial Statement

#000143774915014383 Filed on July 31, 2015

Income Statement

Concept	2015 Q2	2015	2014 Q2
Revenue	$134.4M	$539.3M	$120.9M
YoY Change	11.18%	13.1%	12.9%
Cost Of Revenue	$115.8M	$473.9M	$104.8M
YoY Change	10.5%	14.39%	11.37%
Gross Profit	$18.67M	$65.41M	$16.14M
YoY Change	15.64%	4.54%	23.89%
Gross Profit Margin	13.88%	12.13%	13.35%
Selling, General & Admin	$10.90M	$39.96M	$9.200M
YoY Change	18.48%	13.61%	46.03%
% of Gross Profit	58.39%	61.09%	56.99%
Research & Development	$1.600M	$6.988M	$1.600M
YoY Change	0.0%	-3.0%	-40.74%
% of Gross Profit	8.57%	10.68%	9.91%
Depreciation & Amortization	$1.910M	$7.090M	$1.750M
YoY Change	9.14%	-0.34%	-1.13%
% of Gross Profit	10.23%	10.84%	10.84%
Operating Expenses	$12.40M	$46.95M	$10.80M
YoY Change	14.81%	10.79%	21.35%
Operating Profit	$6.268M	$18.46M	$5.343M
YoY Change	17.31%	-8.56%	29.37%
Interest Expense	$0.00	$1.829M	$0.00
YoY Change		10.85%	-100.0%
% of Operating Profit	0.0%	9.91%	0.0%
Other Income/Expense, Net	$400.0K		$1.900M
YoY Change	-78.95%		5.56%
Pretax Income	$6.600M	$21.47M	$7.200M
YoY Change	-8.33%	-28.19%	24.14%
Income Tax	$2.300M	$7.746M	$2.600M
% Of Pretax Income	34.85%	36.08%	36.11%
Net Earnings	$4.196M	$13.54M	$4.500M
YoY Change	-6.76%	-29.26%	0.0%
Net Earnings / Revenue	3.12%	2.51%	3.72%
Basic Earnings Per Share	$0.16	$0.50	$0.17
Diluted Earnings Per Share	$0.15	$0.50	$0.17
COMMON SHARES
Basic Shares Outstanding		26.88M
Diluted Shares Outstanding		27.34M

Balance Sheet

Concept	2015 Q2	2015	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.10M	$14.10M	$14.20M
YoY Change	-0.7%	-0.7%	-7.19%
Cash & Equivalents	$14.13M	$14.10M	$14.24M
Short-Term Investments
Other Short-Term Assets	$7.400M	$7.400M	$5.300M
YoY Change	39.62%	39.62%	17.78%
Inventory	$25.03M	$25.00M	$24.74M
Prepaid Expenses
Receivables	$46.48M	$46.50M	$44.42M
Other Receivables	$100.0K	$100.0K	$2.000M
Total Short-Term Assets	$93.20M	$93.20M	$90.93M
YoY Change	2.5%	2.53%	6.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$84.47M	$84.50M	$74.14M
YoY Change	13.93%	14.04%	12.66%
Goodwill	$49.62M		$49.62M
YoY Change	0.0%		0.0%
Intangibles	$48.43M		$48.43M
YoY Change	0.0%		0.0%
Long-Term Investments	$61.50M	$61.50M	$40.40M
YoY Change	52.23%	52.23%	32.89%
Other Assets	$1.415M	$1.400M	$1.393M
YoY Change	1.58%	0.0%	-2.18%
Total Long-Term Assets	$253.3M	$253.3M	$222.7M
YoY Change	13.73%	13.74%	8.48%
TOTAL ASSETS
Total Short-Term Assets	$93.20M	$93.20M	$90.93M
Total Long-Term Assets	$253.3M	$253.3M	$222.7M
Total Assets	$346.5M	$346.5M	$313.6M
YoY Change	10.47%	10.49%	7.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$35.01M	$35.00M	$31.98M
YoY Change	9.47%	9.03%	1.62%
Accrued Expenses	$10.70M	$10.70M	$9.000M
YoY Change	18.89%	18.89%	23.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$8.353M	$8.400M	$6.055M
YoY Change	37.95%	37.7%	2.06%
Total Short-Term Liabilities	$56.16M	$56.20M	$48.39M
YoY Change	16.05%	16.12%	-4.65%
LONG-TERM LIABILITIES
Long-Term Debt	$34.17M	$34.20M	$28.32M
YoY Change	20.66%	20.85%	-17.62%
Other Long-Term Liabilities	$1.691M	$1.700M	$2.021M
YoY Change	-16.33%	-15.0%	49.81%
Total Long-Term Liabilities	$35.86M	$35.90M	$30.34M
YoY Change	18.19%	18.48%	-15.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$56.16M	$56.20M	$48.39M
Total Long-Term Liabilities	$35.86M	$35.90M	$30.34M
Total Liabilities	$126.4M	$128.0M	$108.9M
YoY Change	16.07%	15.73%	-1.51%
SHAREHOLDERS EQUITY
Retained Earnings	$85.10M		$71.55M
YoY Change	18.93%		36.53%
Common Stock	$27.00K		$27.00K
YoY Change	0.0%		3.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$218.4M	$218.4M	$203.1M
YoY Change
Total Liabilities & Shareholders Equity	$346.5M	$346.5M	$313.6M
YoY Change	10.47%	10.49%	7.8%

Cashflow Statement

Concept	2015 Q2	2015	2014 Q2
OPERATING ACTIVITIES
Net Income	$4.196M	$13.54M	$4.500M
YoY Change	-6.76%	-29.26%	0.0%
Depreciation, Depletion And Amortization	$1.910M	$7.090M	$1.750M
YoY Change	9.14%	-0.34%	-1.13%
Cash From Operating Activities	$13.24M	$26.62M	$7.220M
YoY Change	83.38%	26.46%	-6.84%
INVESTING ACTIVITIES
Capital Expenditures	-$7.310M	$17.51M	-$4.700M
YoY Change	55.53%	17.63%	8.29%
Acquisitions
YoY Change
Other Investing Activities	$150.0K	-$16.93M	$0.00
YoY Change		-1192.26%	-100.0%
Cash From Investing Activities	-$7.160M	-$34.44M	-$4.690M
YoY Change	52.67%	158.17%	124.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$122.0K
YoY Change		-94.69%
Debt Paid & Issued, Net		$6.867M
YoY Change		15.74%
Cash From Financing Activities	-7.650M	7.710M	-1.260M
YoY Change	507.14%	-207.38%	-33.33%
NET CHANGE
Cash From Operating Activities	13.24M	26.62M	7.220M
Cash From Investing Activities	-7.160M	-34.44M	-4.690M
Cash From Financing Activities	-7.650M	7.710M	-1.260M
Net Change In Cash	-1.570M	-110.0K	1.270M
YoY Change	-223.62%	-120.75%	-66.31%
FREE CASH FLOW
Cash From Operating Activities	$13.24M	$26.62M	$7.220M
Capital Expenditures	-$7.310M	$17.51M	-$4.700M
Free Cash Flow	$20.55M	$9.109M	$11.92M
YoY Change	72.4%	47.78%	-1.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2014Q4	dei	Entity Public Float EntityPublicFloat	344754000
CY2010Q2	invest	Derivative Notional Amount DerivativeNotionalAmount	20000000
CY2015	lndc	Annual Letter Of Credit Fee Percentage AnnualLetterOfCreditFeePercentage	0.0075
CY2015	lndc	Annual Remarketing Fee Percentage AnnualRemarketingFeePercentage	0.00125
CY2015Q2	lndc	Decrease In Net Income Before Taxes DecreaseInNetIncomeBeforeTaxes	0.28
CY2014Q2	lndc	Decrease In Net Income Before Taxes DecreaseInNetIncomeBeforeTaxes	0.07
CY2015Q2	lndc	Deferred Tax Asset Research And Amt Credit Carry Forwards DeferredTaxAssetResearchAndAmtCreditCarryForwards	515000
CY2014Q2	lndc	Deferred Tax Asset Research And Amt Credit Carry Forwards DeferredTaxAssetResearchAndAmtCreditCarryForwards	495000
CY2015	lndc	Earn Out Payment From Acquisition EarnOutPaymentFromAcquisition
CY2014	lndc	Earn Out Payment From Acquisition EarnOutPaymentFromAcquisition
CY2013	lndc	Earn Out Payment From Acquisition EarnOutPaymentFromAcquisition	9650000
CY2015	lndc	Earnout Liability EarnoutLiability
CY2014	lndc	Earnout Liability EarnoutLiability
CY2013	lndc	Earnout Liability EarnoutLiability	3933000
CY2015	lndc	Fair Value Inputs Income Tax Rate FairValueInputsIncomeTaxRate	0.15
CY2014	lndc	Fair Value Inputs Income Tax Rate FairValueInputsIncomeTaxRate	0.15
CY2015	lndc	Fair Value Inputs Long Term Expense Growth Rate FairValueInputsLongTermExpenseGrowthRate	0.04
CY2014	lndc	Fair Value Inputs Long Term Expense Growth Rate FairValueInputsLongTermExpenseGrowthRate	0.04
CY2015Q2	lndc	Finite Lived Customer Lists Net FiniteLivedCustomerListsNet	7835000
CY2014Q2	lndc	Finite Lived Customer Lists Net FiniteLivedCustomerListsNet	8720000
CY2015	lndc	Income Tax Reconciliation Change In Value Of Contingent Consideration IncomeTaxReconciliationChangeInValueOfContingentConsideration
CY2015Q2	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	1000000
CY2014Q2	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	656000
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1229000
CY2014Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent
CY2014	lndc	Income Tax Reconciliation Change In Value Of Contingent Consideration IncomeTaxReconciliationChangeInValueOfContingentConsideration
CY2013	lndc	Income Tax Reconciliation Change In Value Of Contingent Consideration IncomeTaxReconciliationChangeInValueOfContingentConsideration	1450000
CY2010Q2	lndc	Interest Rate Swap Term InterestRateSwapTerm	P5Y
CY2015Q2	lndc	Number Of Proprietary Platforms NumberOfProprietaryPlatforms	2
CY2015Q2	lndc	Payment On Purchase Commitments PaymentOnPurchaseCommitments	16800000
CY2015Q2	lndc	Sensitivity Analysis Of Fair Value Of Interests Continued To Be Held By Transferor Servicing Assets Or Liabilities Impact Of10 Percent Adverse Change In Expense Growth Rates SensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrLiabilitiesImpactOf10PercentAdverseChangeInExpenseGrowthRates	-1200000
CY2015Q2	lndc	Sensitivity Analysis Of Fair Value Of Interests Continued To Be Held By Transferor Servicing Assets Or Liabilities Impact Of10 Percent Adverse Change In Income Tax Rates SensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrLiabilitiesImpactOf10PercentAdverseChangeInIncomeTaxRates	-100000
CY2015Q2	lndc	Sensitivity Analysis Of Fair Value Of Interests Continued To Be Held By Transferor Servicing Assets Or Liabilities Impact Of10 Percent Adverse Change In Revenue Growth Rates SensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrLiabilitiesImpactOf10PercentAdverseChangeInRevenueGrowthRates	2300000
CY2014Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Expirations SharebasedCompensationArrangementBySharebasedPaymentAwardExpirations	2846
CY2013Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Grants In Period SharebasedCompensationArrangementBySharebasedPaymentAwardGrantsInPeriod	26666
CY2014Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Grants In Period SharebasedCompensationArrangementBySharebasedPaymentAwardGrantsInPeriod	420131
CY2015Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Grants In Period SharebasedCompensationArrangementBySharebasedPaymentAwardGrantsInPeriod	1118857
CY2015Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	123261000
CY2015Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Expected To Vest Outstanding Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedToVestOutstandingNumber	861612
CY2015Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Expected To Vest Outstanding Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedToVestOutstandingWeightedAverageExercisePrice	14.22
CY2015	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Expected To Vest Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedToVestOutstandingWeightedAverageRemainingContractualTerm	P6Y251D
CY2015Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Outstanding Aggregate Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue	5328606000
CY2015Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Outstanding Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedOutstandingNumber	849464
CY2014Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Outstanding Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedOutstandingNumber	984610
CY2015Q2	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Outstanding Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedOutstandingWeightedAverageExercisePrice	8.02
CY2015	lndc	Sharebased Compensation Arrangement By Sharebased Payment Award Optionsvested Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsvestedOutstandingWeightedAverageRemainingContractualTerm	P2Y270D
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	34765000
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	31981000
CY2015Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	244000
CY2014Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	134000
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46173000
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	-50222000
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	44421000
CY2015Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	306000
CY2014Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	304000
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	-44831000
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	133307000
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	131488000
CY2015	us-gaap	Advertising Expense AdvertisingExpense	1300000
CY2014	us-gaap	Advertising Expense AdvertisingExpense	447000
CY2013	us-gaap	Advertising Expense AdvertisingExpense	445000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1577000
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1356000
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1695000
CY2012Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	512000
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	583000
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	516000
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	382000
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	382000
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	516000
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	109000
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	143000
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	-38000
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	-210000
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	-134000
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-951000
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-886000
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-885000
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	371115
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	333993
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	88022
CY2015Q2	us-gaap	Assets Assets	346465000
CY2014Q2	us-gaap	Assets Assets	313623000
CY2013Q2	us-gaap	Assets Assets	290942000
CY2015Q2	us-gaap	Assets Current AssetsCurrent	93202000
CY2014Q2	us-gaap	Assets Current AssetsCurrent	90929000
CY2015Q2	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	0
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13718000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22177000
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-116000
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	525000
CY2014Q2	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	0
CY2015Q2	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	0
CY2015	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	509000
CY2014	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	913000
CY2013	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	0
CY2015	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	158000
CY2014	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	189000
CY2013	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	160000
CY2014Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1100000
CY2015Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1100000
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14127000
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14243000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8459000
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	881143
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26990490
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26815253
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26990490
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26815253
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	27000
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	27000
CY2015	us-gaap	Common Stock Voting Rights CommonStockVotingRights	1
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2353000
CY2014Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3223000
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3772000
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4196000
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13544000
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4752000
CY2013Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3451000
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6400000
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4542000
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19145000
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4366000
CY2012Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8913000
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3789000
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5059000
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	6218000
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4152000
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5585000
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6606000
CY2015Q2	us-gaap	Deferred Revenue DeferredRevenue	843000
CY2014Q2	us-gaap	Deferred Revenue DeferredRevenue	1300000
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	843000
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1254000
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	363000
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	526000
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	388000
CY2015Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7522000
CY2014Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7139000
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4789000
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4519000
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	22587000
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Concentrations of Risk</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash and cash equivalents, marketable securities, trade accounts receivable, grower advances and notes receivable are financial instruments that potentially subject the Company to concentrations of credit risk. Our Company policy limits, among other things, the amount of credit exposure to any one issuer and to any one type of investment, other than securities issued or guaranteed by the U.S. government. The Company routinely assesses the financial strength of customers and growers and, as a consequence, believes that trade receivables, grower advances and notes receivable credit risk exposure is limited. Credit losses for bad debt are provided for in the consolidated financial statements through a charge to operations. A valuation allowance is provided for known and anticipated credit losses. The recorded amounts for these financial instruments approximate their fair value.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Several of the raw materials we use to manufacture our products are currently purchased from a single source, including some monomers used to synthesize Intelimer polymers, substrate materials for our breathable membrane products and raw materials for our HA products.  </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The operations of Windset, in which the Company holds a 26.9% minority investment, are predominantly located in British Columbia and Santa Maria, California. Routinely, the Company evaluates the financial strength and ability for Windset to continue as a going concern.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the fiscal year ended May 31, 2015, sales to the Company’s top five customers accounted for approximately 46% of total revenue with the top two customers from the Food Products Technology segment, Costco Wholesale Corporation (“Costco”) and Wal-mart, Inc. (“Wal-mart”) accounting for approximately 21% and 11%, respectively, of total revenues. In addition, approximately 30% of the Company’s total revenues were derived from product sales to international customers, none of which individually accounted for more than 5% of total revenues. As of May 31, 2015, the top two customers, Costco and Wal-mart represented approximately 15% and 13%, respectively, of total accounts receivable.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the fiscal year ended May 25, 2014, sales to the Company’s top five customers accounted for approximately 42% of total revenue with the top two customers from the Food Products Technology segment, Costco Wholesale Corporation and Wal-mart, Inc. accounting for approximately 21% and 11%, respectively, of total revenues. In addition, approximately 29% of the Company’s total revenues were derived from product sales to international customers, none of which individually accounted for more than 5% of total revenues. As of May 25, 2014, the top two customers, Costco Wholesale Corporation and Wal-mart, Inc. represented approximately 16% and 12%, respectively, of total accounts receivable.</div></div></div></div></div></div></div></div></div></div></div>
CY2015Q2	us-gaap	Cost Method Investments CostMethodInvestments
CY2014Q2	us-gaap	Cost Method Investments CostMethodInvestments	793000
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	473850000
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	414249000
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	378948000
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3480000
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4785000
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2808000
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	71000
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	56000
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	56000
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3594000
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4998000
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2846000
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	43000
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	157000
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-18000
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2015Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-32229000
CY2014Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-28077000
CY2015Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6288000
CY2014Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6258000
CY2015Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2111000
CY2014Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2056000
CY2015Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3415000
CY2014Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3630000
CY2015Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	966000
CY2014Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	545000
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	662000
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	723000
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1964000
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1746000
CY2015Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1234000
CY2014Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	881000
CY2015Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	38517000
CY2014Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	34335000
CY2015Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	20578000
CY2014Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	19360000
CY2015Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	34340000
CY2014Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	30133000
CY2015Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	7186000
CY2014Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5705000
CY2015Q2	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	10753000
CY2014Q2	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	9270000
CY2015	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1200000
CY2014	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1100000
CY2013	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	939000
CY2015	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2015	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.67
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6200000
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6200000
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6300000
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7090000
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7114000
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7295000
CY2010Q2	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	20000000
CY2015Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0
CY2014Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	44000
CY2010Q2	us-gaap	Derivative Swaption Interest Rate DerivativeSwaptionInterestRate	0.0424
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
CY2014	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.87
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.50
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.3
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.36
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6742000
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4096000
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7600000
CY2015	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y219D
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	463000
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1922000
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1302000
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	463000
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1922000
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1302000
CY2015	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	3900000
CY2014	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	10000000
CY2013	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	8100000
CY2015	us-gaap	Fair Value Inputs Long Term Revenue Growth Rate FairValueInputsLongTermRevenueGrowthRate	0.04
CY2014	us-gaap	Fair Value Inputs Long Term Revenue Growth Rate FairValueInputsLongTermRevenueGrowthRate	0.04
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	61500000
CY2014Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	39600000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	885000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	885000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	885000
CY2014Q2	us-gaap	Goodwill Goodwill	49620000
CY2013Q3	us-gaap	Gross Profit GrossProfit	12532000
CY2013Q4	us-gaap	Gross Profit GrossProfit	13734000
CY2013	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
	us-gaap	Gross Profit GrossProfit	14188000
CY2014Q4	us-gaap	Gross Profit GrossProfit	15666000
CY2015Q1	us-gaap	Gross Profit GrossProfit	16885000
CY2015Q2	us-gaap	Gross Profit GrossProfit	18668000
CY2015	us-gaap	Gross Profit GrossProfit	65407000
CY2014Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	4800000
CY2015Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	4800000
CY2012Q3	us-gaap	Gross Profit GrossProfit	13763000
CY2012Q4	us-gaap	Gross Profit GrossProfit	18459000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	885000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	885000
CY2012Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	58985000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	58034000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	57148000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	56263000
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	90000
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-329000
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-217000
CY2015Q2	us-gaap	Goodwill Goodwill	49620000
CY2014Q1	us-gaap	Gross Profit GrossProfit	20155000
CY2014Q2	us-gaap	Gross Profit GrossProfit	16143000
CY2014	us-gaap	Gross Profit GrossProfit	62564000
CY2013Q1	us-gaap	Gross Profit GrossProfit	17508000
CY2013Q2	us-gaap	Gross Profit GrossProfit	13030000
CY2013	us-gaap	Gross Profit GrossProfit	62760000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7746000
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10583000
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9452000
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	353000
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	99000
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	370000
CY2015	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	369000
CY2014	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	406000
CY2013	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	172000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	7451000
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	10405000
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	11214000
CY2015	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	120000
CY2014	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	152000
CY2013	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-440000
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	566000
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	711000
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	731000
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	375000
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	378000
CY2013	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	801000
CY2015	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome
CY2014	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome
CY2013	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	150000
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	50000
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	5605000
CY2015Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	152000
CY2014Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2000000
CY2014	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-91000
CY2013	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	10000
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2784000
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-50000
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8826000
CY2015	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	110000
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1229000
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1218000
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3211000
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2486000
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-411000
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	6000
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1086000
CY2015	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	2000
CY2014	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-12000
CY2013	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	348000
CY2015	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2646000
CY2014	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	38000
CY2013	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-798000
CY2015	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-2313000
CY2014	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-5025000
CY2013	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	3754000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	292000
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	622000
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2102000
CY2015	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	5691000
CY2014	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	4763000
CY2013	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	4173000
CY2015	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	24000
CY2014	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-31000
CY2013	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-712000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2175000
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	32000
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	278000
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1752000
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	7994000
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4121000
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	452
CY2014	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	492
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	796
CY2015Q2	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	48428000
CY2014Q2	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	48428000
CY2015	us-gaap	Interest Expense InterestExpense	1829000
CY2014	us-gaap	Interest Expense InterestExpense	1650000
CY2013	us-gaap	Interest Expense InterestExpense	2008000
CY2015	us-gaap	Interest Paid InterestPaid	1994000
CY2014	us-gaap	Interest Paid InterestPaid	1504000
CY2013	us-gaap	Interest Paid InterestPaid	1728000
CY2015Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13271000
CY2014Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11111000
CY2015Q2	us-gaap	Inventory Net InventoryNet	25027000
CY2014Q2	us-gaap	Inventory Net InventoryNet	24735000
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8877000
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4959000
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17511000
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14886000
CY2013	us-gaap	Net Income Loss NetIncomeLoss	22587000
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	181000
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	197000
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	225000
CY2015Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	9879000
CY2014Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	10376000
CY2015Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1877000
CY2014Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3248000
CY2015	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1417000
CY2014	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1125000
CY2013	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1125000
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	315000
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	260000
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	179000
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5000000
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4400000
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4800000
CY2015Q2	us-gaap	Liabilities Liabilities	126356000
CY2014Q2	us-gaap	Liabilities Liabilities	108862000
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	346465000
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	313623000
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	56159000
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	48391000
CY2015Q2	us-gaap	Long Term Debt LongTermDebt	42519000
CY2014Q2	us-gaap	Long Term Debt LongTermDebt	34372000
CY2015Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	8353000
CY2014Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	6055000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	10157000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	8353000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6655000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6005000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5782000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5567000
CY2015Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34166000
CY2014Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	28317000
CY2015Q2	us-gaap	Minority Interest MinorityInterest	1677000
CY2014Q2	us-gaap	Minority Interest MinorityInterest	1692000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	8169000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-7179000
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-19267000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-34440000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-13341000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-10422000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	26155000
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	21045000
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	21230000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	13544000
CY2014	us-gaap	Net Income Loss NetIncomeLoss	19145000
CY2015	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2015	us-gaap	Operating Expenses OperatingExpenses	46946000
CY2014	us-gaap	Operating Expenses OperatingExpenses	42374000
CY2013	us-gaap	Operating Expenses OperatingExpenses	37892000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	18461000
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	20190000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	24868000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	9419000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	3136000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	257000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1003000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1768000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2631000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	624000
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3983000
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4871000
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1415000
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1393000
CY2015	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	21471000
CY2014	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	29925000
CY2013	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	32264000
CY2015	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	7746000
CY2014	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	10583000
CY2013	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	9452000
CY2015	us-gaap	Other Expenses OtherExpenses
CY2014	us-gaap	Other Expenses OtherExpenses
CY2013	us-gaap	Other Expenses OtherExpenses	-3933000
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1691000
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2021000
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3107000
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10000000
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8100000
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	163460000
CY2014	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	137246000
CY2013	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	132766000
CY2015	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	793000
CY2014	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
CY2013	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	343000
CY2014	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1271000
CY2013	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	49000
CY2015	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	18000000
CY2014	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments
CY2013	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1417000
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3170000
CY2015	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	5730000
CY2014	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	4481000
CY2013	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	4173000
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	109479000
CY2013Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	120026000
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	126379000
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	441708000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	133614000
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5306000
CY2014Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	132665000
CY2015	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	196000
CY2014	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	226000
CY2013	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	320000
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	122000
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2298000
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3416000
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15014000
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt
CY2015	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	30417000
CY2014	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9500000
CY2013	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2014	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2962000
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3414000
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1071000
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2015	us-gaap	Profit Loss ProfitLoss	13725000
CY2014	us-gaap	Profit Loss ProfitLoss	19342000
CY2013	us-gaap	Profit Loss ProfitLoss	22812000
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	134687000
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	118971000
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84465000
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74140000
CY2015Q2	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	15100000
CY2012Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	114654000
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	138530000
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	134448000
CY2015	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	30417000
CY2014	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	13500000
CY2013	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	7666000
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6867000
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5933000
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7012000
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6988000
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7204000
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9294000
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	85098000
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	71554000
CY2015	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Deferred Revenue</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash received in advance of services performed are recorded as deferred revenue. At May 31, 2015, $843,000 was recognized as advances from customers. At May 25, 2014, $1.3 million was recognized as advances from customers. </div></div></div></div></div></div></div></div></div></div></div>
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	539257000
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	476813000
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	120929000
CY2012Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	102074000
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	117867000
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	107113000
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	539257000
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	476813000
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	441708000
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39958000
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35170000
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32531000
CY2015Q2	us-gaap	Sensitivity Analysis Of Fair Value Of Interests Continued To Be Held By Transferor Servicing Assets Or Liabilities Impact Of10 Percent Adverse Change In Discount Rate SensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrLiabilitiesImpactOf10PercentAdverseChangeInDiscountRate	-1500000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	1577000
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	1356000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	1695000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.0032
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.0041
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.0053
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.01
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0071
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0048
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	2000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	449643
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	422977
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2000000
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	881143
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1500000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.42
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.41
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.57
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.02
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.15
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.80
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	5451867000
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1711076
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	11.14
CY2015Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	663673
CY2015Q2	us-gaap	Share Price SharePrice	14.29
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y91D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y182D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y277D
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	887254
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	231250
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y266D
CY2015	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	112443
CY2014	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	47573
CY2013	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	145159
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2010Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	218432000
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	203069000
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	220109000
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	204761000
CY2014	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2015	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2013	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2015Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	987000
CY2014Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1035000
CY2013Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	998000
CY2012Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	766000
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	141000
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	48000
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	76000
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	78000
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	129000
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	17000
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	7000
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	103000
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2015Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	800000
CY2014Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	817000
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make certain estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most significant and subjective judgments include revenue recognition; sales returns and allowances; self insurance liabilities;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived assets; the valuation of intangible assets and inventory; the valuation of investments; and the valuation and recognition of stock-based compensation.</div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">These estimates involve the consideration of complex factors and require management to make judgments. The analysis of historical and future trends can require extended periods of time to resolve and are subject to change from period to period. The actual results may differ from management’s estimates.</div></div></div></div></div></div></div></div></div></div></div>
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	353000
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27336
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27120
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26626
CY2015	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	26884
CY2014	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	26628
CY2013	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	25830
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26884
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26628
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25830

Files In Submission

Name	View Source	Status
0001437749-15-014383-index-headers.html	Edgar Link	pending
0001437749-15-014383-index.html	Edgar Link	pending
0001437749-15-014383.txt	Edgar Link	pending
0001437749-15-014383-xbrl.zip	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image.jpg	Edgar Link	pending
lndc-20150531.xml	Edgar Link	completed
lndc-20150531.xsd	Edgar Link	pending
lndc-20150531_cal.xml	Edgar Link	unprocessable
lndc-20150531_def.xml	Edgar Link	unprocessable
lndc-20150531_lab.xml	Edgar Link	unprocessable
lndc-20150531_pre.xml	Edgar Link	unprocessable
lndc20150524_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2015 Q2 Form 10-K Financial Statement

#000143774915014383 Filed on July 31, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2015 Q2 Form 10-K Financial Statement

#000143774915014383 Filed on July 31, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr